X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (70) 70
index medicus (68) 68
oncology (53) 53
prognosis (34) 34
cancer (33) 33
female (33) 33
male (32) 32
middle aged (32) 32
aged (28) 28
chemotherapy (23) 23
analysis (20) 20
disease-free survival (20) 20
breast cancer (19) 19
survival (19) 19
treatment outcome (17) 17
care and treatment (16) 16
antineoplastic agents - therapeutic use (15) 15
metastasis (15) 15
retrospective studies (14) 14
aged, 80 and over (13) 13
prostate cancer (13) 13
adult (12) 12
hematology, oncology and palliative medicine (12) 12
tumors (12) 12
urology & nephrology (12) 12
lymphocytes (11) 11
neoplasm staging (11) 11
proportional hazards models (11) 11
men (10) 10
neoplasms - drug therapy (10) 10
neutrophils (10) 10
research (10) 10
survival rate (10) 10
urology (10) 10
antineoplastic agents - adverse effects (9) 9
breast neoplasms - pathology (9) 9
clinical trials (9) 9
kaplan-meier estimate (9) 9
medical prognosis (9) 9
prostatic neoplasms, castration-resistant - drug therapy (9) 9
randomized controlled trials as topic (9) 9
biomarkers (8) 8
carcinoma (8) 8
further section (8) 8
lymphocyte count (8) 8
meta-analysis (8) 8
studies (8) 8
survival analysis (8) 8
therapy (8) 8
breast neoplasms - mortality (7) 7
neoplasm metastasis (7) 7
neutrophil-to-lymphocyte ratio (7) 7
patients (7) 7
risk factors (7) 7
solid tumors (7) 7
association (6) 6
breast neoplasms - drug therapy (6) 6
cancer therapies (6) 6
clinical-trials (6) 6
disease progression (6) 6
double-blind (6) 6
lymphocytes - pathology (6) 6
neutrophils - pathology (6) 6
odds ratio (6) 6
patient outcomes (6) 6
predictive value of tests (6) 6
prospective studies (6) 6
research article (6) 6
biomarkers, tumor - blood (5) 5
biomarkers, tumor - metabolism (5) 5
breast-cancer (5) 5
cells (5) 5
development and progression (5) 5
diagnosis (5) 5
drug approval (5) 5
further section · weitere sektionen (5) 5
inflammation (5) 5
leukocyte count (5) 5
medicine & public health (5) 5
mortality (5) 5
pretreatment neutrophil (5) 5
prostate-specific antigen - blood (5) 5
quality-of-life (5) 5
risk (5) 5
trial (5) 5
antineoplastic agents (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
breast neoplasms - genetics (4) 4
breast neoplasms - metabolism (4) 4
breast neoplasms - therapy (4) 4
carcinoma, renal cell - drug therapy (4) 4
castration-resistant prostate cancer (4) 4
cell lung-cancer (4) 4
chemotherapy, adjuvant (4) 4
docetaxel (4) 4
drugs (4) 4
efficacy (4) 4
gene expression (4) 4
gene expression regulation, neoplastic (4) 4
mcrpc (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e18158 - e18158
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. e16095 - e16095
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2016, Volume 34, Issue 2_suppl, pp. 213 - 213
213 Background: Daily oral prednisone (P) has been employed for the therapy of mCRPC, alone or in combination regimens. Despite palliative benefits and PSA... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2015, Volume 33, Issue 7_suppl, pp. 186 - 186
186 Background: In men with mCRPC receiving chemotherapy, measurable disease response by World Health Organization criteria has been demonstrated to be... 
Journal Article
Journal Article
Molecular Cancer, ISSN 1476-4598, 08/2017, Volume 16, Issue 1, pp. 137 - 7
Journal Article
Journal Article
Swiss Medical Forum ‒ Schweizerisches Medizin-Forum, ISSN 1424-3784, 09/2014, Volume 14, Issue 37
Journal Article
Cancer Epidemiology Biomarkers and Prevention, ISSN 1055-9965, 2014, Volume 23, Issue 7, pp. 1204 - 1212
Background: Inflammation influences cancer development and progression. An elevated platelet to lymphocyte ratio (PLR), a marker of inflammation, has been... 
SURVIVAL | CELLS | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | PREDICTOR | ONCOLOGY | MARKER | SCORES | SUPERIOR | NEUTROPHIL-LYMPHOCYTE | INFLAMMATORY RESPONSE | INTERLEUKIN-6 | CANCER | Lymphocyte Count | Neoplasms - mortality | Neoplasms - blood | Platelet Count | Prognosis | Humans
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. 6588 - 6588
Journal Article
Journal Article